INPP4A and hepatocellular carcinoma: MiR-3127 upregulation sustained PI3K/AKT signaling by directly suppressing PHLPP1, PHLPP2, INPP4A, and INPP5J expression, and induced an aggressive phenotype of HCC both in vitro and in vivo.